irinotecan
rex medical ltd - irinotecan hydrochloride trihydrate 20 mg/ml; - solution for injection - 20 mg/ml - active: irinotecan hydrochloride trihydrate 20 mg/ml excipient: lactic acid sodium hydroxide sorbitol water for injection
campto 20 mg/ml inf. sol. (conc.) i.v. vial
pfizer sa-nv - irinotecan hydrochloride trihydrate 20 mg/ml - eq. irinotecan 17,33 mg/ml - concentrate for solution for infusion - 20 mg/ml - irinotecan hydrochloride trihydrate 20 mg/ml - topoisomerase 1 (top1) inhibitors
campto 20 mg/ml inf. sol. (conc.) i.v. vial
pfizer sa-nv - irinotecan hydrochloride trihydrate 20 mg/ml - eq. irinotecan 17,33 mg/ml - concentrate for solution for infusion - 20 mg/ml - irinotecan hydrochloride trihydrate 20 mg/ml - topoisomerase 1 (top1) inhibitors
campto 20 mg/ml inf. sol. (conc.) i.v. vial
pfizer sa-nv - irinotecan hydrochloride trihydrate 20 mg/ml - eq. irinotecan 17,33 mg/ml - concentrate for solution for infusion - 20 mg/ml - irinotecan hydrochloride trihydrate 20 mg/ml - topoisomerase 1 (top1) inhibitors
irinotecan viatris 100 mg/5 ml inf. sol. (conc.) i.v. vial
viatris gx bv-srl - irinotecan hydrochloride trihydrate 20 mg/ml - eq. irinotecan 17,33 mg/ml - concentrate for solution for infusion - 20 mg/ml - irinotecan hydrochloride trihydrate 20 mg/ml - irinotecan
irinotecan viatris 40 mg/2 ml inf. sol. (conc.) i.v. vial
viatris gx bv-srl - irinotecan hydrochloride trihydrate 20 mg/ml - eq. irinotecan 17,33 mg/ml - concentrate for solution for infusion - 20 mg/ml - irinotecan hydrochloride trihydrate 20 mg/ml - irinotecan
irinotecan viatris 300 mg/15 ml inf. sol. (conc.) i.v. vial
viatris gx bv-srl - irinotecan hydrochloride trihydrate 20 mg/ml - eq. irinotecan 17,33 mg/ml - concentrate for solution for infusion - 20 mg/ml - irinotecan hydrochloride trihydrate 20 mg/ml - irinotecan
irinotecan viatris 500 mg/25 ml inf. sol. (conc.) i.v. vial
viatris gx bv-srl - irinotecan hydrochloride trihydrate 20 mg/ml - eq. irinotecan 17,33 mg/ml - concentrate for solution for infusion - 20 mg/ml - irinotecan hydrochloride trihydrate 20 mg/ml - irinotecan
irinotecan hydrochloride 20 mg/ml concentrate for soln for inf
actavis group hf - irinotecan hydrochloride trihydrate - concentrate for soln for inf - 20 mg/ml - other antineoplastic agents
dbl irinotecan injection 500mg/25ml irinotecan hydrochloride trihydrate 500mg/25ml concentrated injection vial
pfizer australia pty ltd - irinotecan hydrochloride trihydrate, quantity: 500 mg - injection, concentrated - excipient ingredients: sorbitol; lactic acid; water for injections - irinotecan injection concentrate is indicated as a component of first-line therapy for patients with metastatic carcinoma of the colon or rectum. irinotecan injection concentrate is also indicated for patients with metastatic carcinoma of the colon or rectum whose disease has recurred or progressed following initial therapy.